Inhibition of enhanced toxin production by Clostridium difficile in biotin-limited conditions

Journal of Medical Microbiology

Volumn 47, Issue 9, 1998, Pages 767-771

  Yamakawa, K ^a   Karasawa, T ^a   Ohta, T ^b   Hayashi, H ^b   Nakamura, S ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; BACTERIAL TOXIN; BIOTIN; BOTULINUM TOXIN; GLUTAMIC ACID; GLUTAMINE; LYSINE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; TOXIN SYNTHESIS;

CLOSTRIDIUM DIFFICILE;

EID: 0031718661     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-9-767     Document Type: Article

References (18)

1. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1: 1-18.
2. Dove CH, Wang S-Z, Price SB et al. Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 1990; 58: 480-488.
3. Johnson JL, Phelps C, Barroso L, Roberts MD, Lyerly DM, Wilkins TD. Cloning and expression of the toxin B gene of Clostridium difficile. Curr Microbiol 1990; 20: 397-401.
4. Just I, Wilm M, Selzer J et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 1995; 270: 13932-13936.
5. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995; 375: 500-503.
6. Yamakawa K, Karasawa T, Ikoma S, Nakamura S. Enhancement of Clostridium difficile toxin production in biotin-limited conditions. J Med Microbiol 1996; 44: 111-114.
7. Lehninger AL, Nelson DL, Cox MM. Principles of biochemistry, 2nd edn. New York, Worth Publishers. 1993.
8. Yamakawa K, Kamiya S, Meng XQ, Karasawa T, Nakamura S. Toxin production by Clostridium difficile in a defined medium with limited amino acids. J Med Microbiol 1994; 41: 319-323.
9. Haslam SC, Ketley JM, Mitchell TJ, Stephen J, Burdon DW, Candy DCA. Growth of Clostridium difficile and production of toxins A and B in complex and defined media. J Med Microbiol 1986; 21: 293-297.
10. Karasawa T, Ikoma S, Yamakawa K, Nakamura S. A defined growth medium for Clostridium difficile. Microbiology 1995; 141: 371-375.
11. Kamiya S, Ogura H, Meng XQ, Nakamura S. Correlation between cytotoxin production and sporulation in Clostridium difficile. J Med Microbiol 1992; 37: 206-210.
12. Patterson-Curtis SI, Johnson EA. Regulation of neurotoxin and protease formation in Clostridium botulinum Okra B and Hall A by arginine. Appl Environ Microbiol 1989; 55: 1544-1548.
13. Leyer GJ, Johnson EA. Repression of toxin production by tryptophan in Clostridium botulinum type E. Arch Microbiol 1990; 154: 443-447.
14. Andreesen JR, Bahl H, Gottschalk G. Introduction to the physiology and biochemistry of the genus Clostridium. In: Minton NP, Clarke DJ (eds) Clostridia. New York, Plenum Press. 1989: 27-62.
15. Braun V, Hundsberger T, Leukel P, Souerborn M, von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 1996; 181: 29-38.
16. Hammond GA, Lyerly DM, Johnson JL. Transcriptional analysis of the toxigenic element of Clostridium difficile. Microb Pathog 1997; 22: 143-154.
17. Hundsberger T, Braun V, Weidmann M, Leukel P, Sauerborn M, von Eichel-Streiber C. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem 1997; 244: 735-742.
18. Moncrief JS, Barroso LA, Wilkins TD. Positive regulation of Clostridium difficile toxins. Infect Immun 1997; 65: 1105-1108.